BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19037044)

  • 1. Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology.
    Moscicki AB; Ma Y; Wibbelsman C; Powers A; Darragh TM; Farhat S; Shaber R; Shiboski S
    Obstet Gynecol; 2008 Dec; 112(6):1335-1342. PubMed ID: 19037044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human papillomavirus types 16, 18, and 45 in women with cervical intraepithelial changes: associations with colposcopic and histological findings.
    Jarienė K; Vaitkienė D; Bartusevičius A; Tvarijonavičienė E; Minkauskienė M; Nadišauskienė R; Kruminis V; Kliučinskas M
    Medicina (Kaunas); 2012; 48(1):22-30. PubMed ID: 22481371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
    Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
    JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [To analyse the histopathological results of patients with HPV16/18 positive and colposcopic suspicious lesions].
    Zhang JX; Zheng TP; Liu J; Wang QX; Zhan YX; Zhang ZY
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):467-472. PubMed ID: 28797154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
    Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
    Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.
    Kim CJ; Lee YS; Kwack HS; Yoon WS; Park TC; Park JS
    Int J Gynecol Cancer; 2010 Aug; 20(6):1067-73. PubMed ID: 20683419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.
    Pretorius RG; Peterson P; Azizi F; Burchette RJ
    Am J Obstet Gynecol; 2006 Nov; 195(5):1260-5. PubMed ID: 17074547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
    Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
    Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
    Louvanto K; Syrjänen KJ; Rintala MA; Grénman SE; Syrjänen SM
    Acta Obstet Gynecol Scand; 2011 Feb; 90(2):167-73. PubMed ID: 21241262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?
    Kabaca C; Giray B; Guray Uzun M; Akis S; Purut YE; Keles Peker E; Cetiner H; Bostanci Ergen E
    Diagn Cytopathol; 2021 Apr; 49(4):480-486. PubMed ID: 33528903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing.
    Tao X; Zhang H; Li J; Zhang H; Xiao J; Zhang L; Zhou X; Sui L; Wang L; Zhao C
    Cancer Cytopathol; 2019 Oct; 127(10):650-657. PubMed ID: 31532582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping of human papillomavirus in triaging of low-grade cervical cytology.
    Söderlund-Strand A; Eklund C; Kemetli L; Grillner L; Törnberg S; Dillner J; Dillner L
    Am J Obstet Gynecol; 2011 Aug; 205(2):145.e1-6. PubMed ID: 21658668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
    Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
    J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM; Lewis H; Smith M; Neal H; Bromhead C; Canfell K
    BMC Infect Dis; 2013 Mar; 13():114. PubMed ID: 23452957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
    Wu P; Xiong H; Yang M; Li L; Wu P; Lazare C; Cao C; Gao P; Meng Y; Zhi W; Lin S; Hu J; Wei J; Ma D; Liu J; Yin P; Xing H
    Gynecol Oncol; 2019 Dec; 155(3):436-443. PubMed ID: 31604662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.